Stay updated on Vobramitamab Dose Levels in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Record history now includes a new revision entry v3.3.4, and the previous revision v3.3.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-01-13T17:48:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Version history shows a new entry Returned: 2025-12-16 and an update to Revision: v3.3.3, with new core sections added (Outcome Measures, Outcome Measures (Results), and Study Status). The item HHS Vulnerability Disclosure and the previous Revision: v3.3.2 were removed.
    Difference
    0.7%
    Check dated 2025-12-23T07:33:28.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the page history, a minor version update with no impact on study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:51:09.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new site revision label, Revision: v3.3.1, was added and Revision: v3.2.0 was removed in the history.
    Difference
    0.1%
    Check dated 2025-11-24T11:06:32.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The site-wide notice about government funding and NIH operating status was removed from the page. The change does not alter study data or core functionality.
    Difference
    0.5%
    Check dated 2025-11-17T06:06:32.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    On 2025-11-05, Adverse Events, Outcome Measures (Results), and Outcome Measures were added. The update also shows the current Study Status and Quality Control Review status.
    Difference
    0.6%
    Check dated 2025-11-10T01:54:12.000Z thumbnail image

Stay in the know with updates to Vobramitamab Dose Levels in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.